Lam Research (NASDAQ:LRCX) Trading Up 6% - Time to Buy? - MarketBeat
π Lam Research shares jumped 6% to a high of $393.07 on Monday with volume increasing by 23% over the daily average.
π° The company beat Q1 earnings estimates, reporting $1.47 EPS and $5.84 billion in revenue compared to analyst expectations.
π Revenue grew 23.8% year-over-year, driven by strong demand for wafer fabrication equipment and AI-related applications.
π Major analysts including Needham & Company, TD Cowen, and JPMorgan Chase maintained 'buy' ratings with price targets between $300 and $340.
β οΈ The stock trades at a high P/E ratio of 73.38, raising concerns about valuation among some investors despite strong fundamentals.
π Insider selling activity was noted, with Director Eric Brandt and SVP Neil J. Fernandes executing pre-arranged sales totaling over $27 million in the last 90 days.
πΈ Lam Research declared a quarterly dividend of $0.26 per share, resulting in an annualized yield of approximately 0.3%.
π The company maintains a strong balance sheet with a debt-to-equity ratio of 0.35 and a current ratio of 2.54.
- Lam Research reported earnings per share of $1.47, significantly beating the consensus estimate of $1.36.
- Revenue reached $5.84 billion, surpassing analyst estimates of $5.70 billion and growing 23.8% year-over-year.
- Major Wall Street analysts including Needham & Company, TD Cowen, Deutsche Bank, and JPMorgan Chase have reaffirmed 'buy' ratings with price targets ranging from $300 to $340.
- The company demonstrated exceptional profitability with a return on equity of 66.21% and a net margin of 30.94%.
- Strong sector momentum in semiconductors and AI-driven demand for wafer fab equipment supports long-term growth prospects.
- The stock's P/E ratio of 73.38 indicates a rich valuation that may limit upside potential if growth slows.
- Significant insider selling occurred in the last 90 days, with insiders selling 86,339 shares worth $27.68 million, which can raise questions about near-term sentiment despite pre-arranged plans.
- Weiss Ratings recently lowered its rating from 'buy (b)' to 'buy (b-)', suggesting some analysts see reduced upside at current levels.